Zydus Lifesciences Limited (ZYDUSLIFE) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.018x

Based on the latest financial reports, Zydus Lifesciences Limited (ZYDUSLIFE) has a cash flow conversion efficiency ratio of 0.018x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.68 Billion ≈ $39.84 Million USD) by net assets (Rs209.41 Billion ≈ $2.26 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ZYDUSLIFE company net worth for the company's overall valuation and market capitalisation.

Zydus Lifesciences Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Zydus Lifesciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zydus Lifesciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zydus Lifesciences Limited ranked by their cash flow conversion efficiency. Explore ZYDUSLIFE cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
PRADA S.P.A.UNS.ADR/2 EO1 F:PRP0	N/A
One 97 Communications Limited NSE:PAYTM	0.003x
Samsung Heavy Industries KO:010140	0.334x
Industrivarden AB ser. A ST:INDU-A	0.042x
Smith & Nephew SNATS Inc NYSE:SNN	0.168x
Manhattan Associates Inc NASDAQ:MANH	0.576x
KERRY GRP PLC ADR/1EO-12 F:KRZA	N/A
YTL Power International Bhd KLSE:6742	0.069x

Annual Cash Flow Conversion Efficiency for Zydus Lifesciences Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Zydus Lifesciences Limited from 2004 to 2025. View ZYDUSLIFE share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs263.58 Billion ≈ $2.85 Billion	Rs67.77 Billion ≈ $732.87 Million	0.257x	+77.78%
2024-03-31	Rs221.02 Billion ≈ $2.39 Billion	Rs31.96 Billion ≈ $345.67 Million	0.145x	+5.89%
2023-03-31	Rs196.88 Billion ≈ $2.13 Billion	Rs26.89 Billion ≈ $290.78 Million	0.137x	+23.67%
2022-03-31	Rs190.54 Billion ≈ $2.06 Billion	Rs21.04 Billion ≈ $227.55 Million	0.110x	-49.93%
2021-03-31	Rs149.30 Billion ≈ $1.61 Billion	Rs32.93 Billion ≈ $356.13 Million	0.221x	+3.10%
2020-03-31	Rs117.10 Billion ≈ $1.27 Billion	Rs25.05 Billion ≈ $270.95 Million	0.214x	-13.31%
2019-03-31	Rs116.79 Billion ≈ $1.26 Billion	Rs28.82 Billion ≈ $311.71 Million	0.247x	+139.88%
2018-03-31	Rs89.36 Billion ≈ $966.34 Million	Rs9.19 Billion ≈ $99.42 Million	0.103x	-45.75%
2017-03-31	Rs71.16 Billion ≈ $769.58 Million	Rs13.49 Billion ≈ $145.94 Million	0.190x	-47.81%
2016-03-31	Rs54.87 Billion ≈ $593.43 Million	Rs19.94 Billion ≈ $215.62 Million	0.363x	+61.65%
2015-03-31	Rs44.20 Billion ≈ $478.06 Million	Rs9.94 Billion ≈ $107.45 Million	0.225x	-9.20%
2014-03-31	Rs35.83 Billion ≈ $387.52 Million	Rs8.87 Billion ≈ $95.93 Million	0.248x	+28.35%
2013-03-31	Rs30.64 Billion ≈ $331.34 Million	Rs5.91 Billion ≈ $63.90 Million	0.193x	+2.37%
2012-03-31	Rs26.64 Billion ≈ $288.10 Million	Rs5.02 Billion ≈ $54.28 Million	0.188x	-37.02%
2011-03-31	Rs22.38 Billion ≈ $242.07 Million	Rs6.70 Billion ≈ $72.41 Million	0.299x	-21.11%
2010-03-31	Rs16.68 Billion ≈ $180.36 Million	Rs6.32 Billion ≈ $68.39 Million	0.379x	+118.22%
2009-03-31	Rs12.58 Billion ≈ $136.05 Million	Rs2.19 Billion ≈ $23.64 Million	0.174x	+1.43%
2008-03-31	Rs10.82 Billion ≈ $116.97 Million	Rs1.85 Billion ≈ $20.04 Million	0.171x	-40.22%
2007-03-31	Rs8.80 Billion ≈ $95.14 Million	Rs2.52 Billion ≈ $27.26 Million	0.287x	+80.46%
2006-03-31	Rs7.00 Billion ≈ $75.66 Million	Rs1.11 Billion ≈ $12.02 Million	0.159x	-58.87%
2005-03-31	Rs5.93 Billion ≈ $64.17 Million	Rs2.29 Billion ≈ $24.78 Million	0.386x	-11.46%
2004-03-31	Rs5.36 Billion ≈ $58.01 Million	Rs2.34 Billion ≈ $25.30 Million	0.436x	--

About Zydus Lifesciences Limited

NSE:ZYDUSLIFE India Drug Manufacturers - Specialty & Generic

Market Cap

$11.96 Billion

Rs1.11 Trillion INR

Market Cap Rank

#1941 Global

#71 in India

Share Price

Rs1099.00

Change (1 day)

-1.80%

52-Week Range

Rs860.60 - Rs1205.00

All Time High

Rs1302.00